These cytokines enhance the expression of the activating receptor NKG2D and the inhibitory receptors CD158a and CD158b on CD8+ T cells, NKT-like cells, and NK-cell subsets in the LNs of melanoma patients. The gene discussed is CD8A; the disease is melanoma.